Romatizmal Hastalığı Olan Çocuklarda COVID-19 Aşılama Pratiği

Mehmet Yıldız; Fatih Haşlak; Aybüke Günalp; Amra Adrovic Yıldız; Sezgin Şahin; Kenan Barut; Özgür Kasapçopur

doi:10.4274/jarem.galenos.2022.44127

Romatizmal Hastalığı Olan Çocuklarda COVID-19 Aşılama Pratiği

PDF

Orijinal Araştırma

Romatizmal Hastalığı Olan Çocuklarda COVID-19 Aşılama Pratiği

J Acad Res Med 2022;12(1):28-35 DOI: 10.4274/jarem.galenos.2022.44127

, , , , ,

PDF

İzin

Öz

Amaç:

Bu kesitsel çalışma, romatizmal hastalığı olan çocukların aşılanma durumlarını ve aşı yaptırmama nedenlerini araştırmak amacıyla yapılmıştır.

Yöntemler:

Kasım 2021’de çocuğu 12 yaşından büyük olan hastaların aileleri ile web tabanlı anket paylaşıldı. Ailelere sosyodemografik özellikleri, çocuklarını aşılma durumları soruldu. Ayrıca aşı yaptırılmayan çocukların ailelerin aşı yaptırmama nedenleri sorgulandı.

Sonuç:

Bu sonuçlar, önceki çalışmaların sonuçlarıyla birlikte, aşı tereddütünün nedenlerinin anlaşılması için ipuçları sağlayabilir ve aşı programlarının kapsamını artırmaya yardımcı olabilir.

Bulgular:

Çalışmaya, dahil edilme kriterlerine uyan 160 hasta (90 kadın) dahil edildi. Çalışma grubumuzda ortanca yaş 14,9 (12-17,9) yıldı. Çalışma grubunu otoenflamatuvar hastalığı olan 94 hasta, juvenil idiyopatik artritli 43 hasta, bağ dokusu hastalığı olan 18 hasta ve vaskülitli 5 hasta oluşturmaktaydı. Hasta grubumuzda ebeveyn tarafından bildirilen aşılama oranı %75 idi. Ortanca çocuk yaşı, ortanca ebeveyn yaşı ve ebeveyn aşılama oranları aşılanmamış hastalarda daha düşüktü (tümü için p-değeri <0,05). Bu çalışmada romatizmal hastalığı olan çocuklara aşı yaptırılmamasının en sık nedenleri aşının yan etkilerinden korkma, henüz karar verilmemiş olma, altta yatan romatizmal hastalık ve kullanılan ilaçlarla ilgili kaygılar olarak belirtilmişti. Hastaların cinsiyeti, tanısı ve kullandıkları ilaçlara göre gruplar arasında fark yoktu. Benzer şekilde, ebeveynlerin eğitim düzeyleri ve çalışma durumları açısından gruplar arasında fark yoktu (tümü için p-değeri >0,05).

Anahtar Kelimeler: Aşı, COVID-19, kararsızlık, romatoloji, çocuklar

Kaynakça

1

Haşlak F, Yıldız M, Adrovic A, Barut K, Kasapçopur Ö. Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon. Balkan Med J 2020; 37: 184-8.

2

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.

3

World Health Organization. WHO Coronavirus (COVID-19) Dashboard [cited 2022 5 January]. Available from: https://covid19.who.int/.

4

World Health Organization. COVID-19 vaccine tracker and landscape 2022 [06 January]. Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines.

5

Pan F, Zhao H, Nicholas S, Maitland E, Liu R, Hou Q. Parents’ Decisions to Vaccinate Children against COVID-19: A Scoping Review. Vaccines (Basel) 2021; 9: 1476.

6

Haslak F, Gunalp A, Cebi MN, Yildiz M, Adrovic A, Sahin S, et al. Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: A single-center study. Int J Rheum Dis 2022.

7

Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis 2021; 21: 1645-53.

8

Committee on Infectious Diseases. COVID-19 Vaccines in Children and Adolescents. Pediatrics 2022; 149: e2021054332.

9

Thomas SJ, Moreira ED Jr, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. N Engl J Med 2021; 385: 1761-73.

10

Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 Infection in Children. N Engl J Med 2020; 382: 1663-5.

11

Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr 2020; 174: 882-9.

12

MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015; 33: 4161-4.

13

World Health Organization. Ten threats to global health in 2019 [cited 2022 6 January]. Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019.

14

Gür E. Vaccine hesitancy - vaccine refusal. Turk Pediatri Ars 2019; 54: 1-2.

15

European Centre for Disease Prevention and Control. COVID-19 Vaccine Tracker 2022 [cited 2022 January 7]. Available from: https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#age-group-tab.

16

Federal Ministry of Health of Germany. Current vaccination status [cited 2022 January 7]. Available from: https://impfdashboard.de/.

17

Ministry of Social Affairs and Health of France. The vaccination dashboard 2022 [cited 2022 January 7]. Available from: https://solidarites-sante.gouv.fr/grands-dossiers/vaccin-covid-19/article/le-tableau-de-bord-de-la-vaccination.

18

Gaur P, Agrawat H, Shukla A. COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey. Rheumatol Int 2021; 41: 1601-5.

19

Priori R, Pellegrino G, Colafrancesco S, Alessandri C, Ceccarelli F, Di Franco M, et al. SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists. Ann Rheum Dis 2021; 80: 953-4.

20

Yurttas B, Poyraz BC, Sut N, Ozdede A, Oztas M, Uğurlu S, et al. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey. Rheumatol Int 2021; 41: 1105-14.

21

Boekel L, Hooijberg F, van Kempen ZLE, Vogelzang EH, Tas SW, Killestein J, et al. Perspective of patients with autoimmune diseases on COVID-19 vaccination. Lancet Rheumatol 2021; 3: e241-e3.

22

Daly M, Robinson E. Willingness to Vaccinate Against COVID-19 in the U.S.: Representative Longitudinal Evidence From April to October 2020. Am J Prev Med 2021; 60: 766-73.

23

Verger P, Peretti-Watel P, Gagneux-Brunon A, Botelho-Nevers E, Sanchez A, Gauna F, et al. Acceptance of childhood and adolescent vaccination against COVID-19 in France: a national cross-sectional study in May 2021. Hum Vaccin Immunother 2021; 17: 5082-8.

24

Goldman RD, Yan TD, Seiler M, Parra Cotanda C, Brown JC, Klein EJ, et al. Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey. Vaccine 2020; 38: 7668-73.

25

Montalti M, Rallo F, Guaraldi F, Bartoli L, Po G, Stillo M, et al. Would Parents Get Their Children Vaccinated Against SARS-CoV-2? Rate and Predictors of Vaccine Hesitancy According to a Survey over 5000 Families from Bologna, Italy. Vaccines (Basel) 2021; 9: 366.

26

Kelly BJ, Southwell BG, McCormack LA, Bann CM, MacDonald PDM, Frasier AM, et al. Predictors of willingness to get a COVID-19 vaccine in the U.S. BMC Infect Dis 2021; 21: 338.

27

Yılmaz M, Sahin MK. Parents’ willingness and attitudes concerning the COVID-19 vaccine: A cross-sectional study. Int J Clin Pract 2021; 75: e14364.

28

Brandstetter S, Böhmer MM, Pawellek M, Seelbach-Göbel B, Melter M, Kabesch M, et al. Parents’ intention to get vaccinated and to have their child vaccinated against COVID-19: cross-sectional analyses using data from the KUNO-Kids health study. Eur J Pediatr 2021; 180: 3405-10.

29

He K, Mack WJ, Neely M, Lewis L, Anand V. Parental Perspectives on Immunizations: Impact of the COVID-19 Pandemic on Childhood Vaccine Hesitancy. J Community Health 2022; 47:39-52.

30

Milan S, Dáu ALBT. The Role of Trauma in Mothers’ COVID-19 Vaccine Beliefs and Intentions. J Pediatr Psychol 2021; 46: 526-35.

31

Wang Z, She R, Chen X, Li L, Li L, Huang Z, et al. Parental acceptability of COVID-19 vaccination for children under the age of 18 years among Chinese doctors and nurses: a cross-sectional online survey. Hum Vaccin Immunother 2021; 17: 3322-32.

32

Akarsu B, Canbay Özdemir D, Ayhan Baser D, Aksoy H, Fidancı İ, Cankurtaran M. While studies on COVID-19 vaccine is ongoing, the public’s thoughts and attitudes to the future COVID-19 vaccine. Int J Clin Pract 2021; 75: e13891.

33

Zhou Y, Zhang J, Wu W, Liang M, Wu QS. Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China. BMC Public Health 2021; 21: 1103.

34

Skjefte M, Ngirbabul M, Akeju O, Escudero D, Hernandez-Diaz S, Wyszynski DF, et al. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol 2021; 36: 197-211.

35

Ruggiero KM, Wong J, Sweeney CF, Avola A, Auger A, Macaluso M, et al. Parents’ Intentions to Vaccinate Their Children Against COVID-19. J Pediatr Health Care 2021; 35: 509-17.

36

Sokol RL, Grummon AH. COVID-19 and Parent Intention to Vaccinate Their Children Against Influenza. Pediatrics 2020; 146: e2020022871.

37

Bell S, Clarke R, Mounier-Jack S, Walker JL, Paterson P. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England. Vaccine 2020; 38: 7789-98.

38

Lv M, Luo X, Shen Q, Lei R, Liu X, Liu E, et al. Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review. Vaccines (Basel) 2021; 9: 1102.

39

Dimopoulou D, Vartzelis G, Dasoula F, Tsolia M, Maritsi D. Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors. Ann Rheum Dis 2021: annrheumdis-2021-221607.